Literature DB >> 1081447

The experimental and clinical use of intravitreal antibiotics to treat bacterial and fungal endophthalmitis.

G A Peyman, D W Vastine, H I Meisels.   

Abstract

The experimental data involving the use of 14 antibacterial and two antifungal agents have been used to establish a rationale for the management of human endophthalmitis. Twelve cases of endophthalmitis treated under our supervision have been described in detail. The eventual visual outcome is related to two factors: (1) time interval between diagnosis and institution of adequate therapy, and (2) the severity of the organism and its ability to produce exotoxins and proteolytic enzymes. Eleven of 12 cases were cured with the recommended dosages of gentamicin and dexamethasone (400 mcg and 360 mcg, respectively). Eight of the 12 patients retained useful vision of 20/200 or better.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081447     DOI: 10.1007/bf00578762

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  48 in total

1.  Observations on the ocular effects of erythromycin.

Authors:  K NAIB; J W HALLETT; I H LEOPOLD
Journal:  Am J Ophthalmol       Date:  1955-03       Impact factor: 5.258

2.  The penetration of several new penicillins into the tissues of the eye.

Authors:  H A DEUR; E R MAAS
Journal:  Ophthalmologica       Date:  1962       Impact factor: 3.250

3.  Prophylaxis and treatment of endophthalmitis.

Authors:  M NEVEU; A J ELLIOT
Journal:  Am J Ophthalmol       Date:  1959-09       Impact factor: 5.258

4.  PENICILLIN AND THE CONTROL OF DEEP INTRA-OCULAR INFECTION.

Authors:  B W Rycroft
Journal:  Br J Ophthalmol       Date:  1945-02       Impact factor: 4.638

5.  Intraocular chloramphenicol and bacterial endophthalmitis.

Authors:  J Koziol; G Peyman
Journal:  Can J Ophthalmol       Date:  1974-07       Impact factor: 1.882

6.  Intravitreal amphotericin B treatment of experimental fungal endophthalmitis.

Authors:  A J Axelrod; G A Peyman
Journal:  Am J Ophthalmol       Date:  1973-10       Impact factor: 5.258

7.  The intraocular penetration of lincomycin.

Authors:  E F Becker
Journal:  Am J Ophthalmol       Date:  1969-06       Impact factor: 5.258

8.  Lincomycin levels in rabbit ocular fluids and serum.

Authors:  R S Coles; G L Boyle; I H Leopold; S S Schneierson
Journal:  Am J Ophthalmol       Date:  1971-08       Impact factor: 5.258

9.  BB-K8: A new aminoglycoside for intravitreal injection in bacterial endophthalmitis.

Authors:  P Nelsen; G A Peyman; T O Bennett
Journal:  Am J Ophthalmol       Date:  1974-07       Impact factor: 5.258

10.  The intravitreal use of carbenicillin (Geopen) for treatment od pseudomonas endophthalmitis.

Authors:  A G Schenk; G A Peyman; J T Paque
Journal:  Acta Ophthalmol (Copenh)       Date:  1974
View more
  8 in total

1.  Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye.

Authors:  B R Kosobucki; W R Freeman; L Cheng
Journal:  Br J Ophthalmol       Date:  2006-03-10       Impact factor: 4.638

2.  Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).

Authors:  Baruch D Kuppermann; Leandro Cabral Zacharias; M Cristina Kenney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

3.  Toxicity and clearance of intravitreal cefotetan.

Authors:  W Philipp; K Schmid; H J Steiner; B Pümpel; F Allerberger; H P Aichberger; W Mayer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 4.  Modeling intraocular bacterial infections.

Authors:  Roger A Astley; Phillip S Coburn; Salai Madhumathi Parkunan; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2016-05-03       Impact factor: 21.198

Review 5.  Nanotechnology in retinal drug delivery.

Authors:  Sibo Jiang; Yesenia L Franco; Yan Zhou; Jianjun Chen
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

6.  Intravitreal penetration of oral pefloxacin in humans.

Authors:  M Oncel; G A Peyman
Journal:  Int Ophthalmol       Date:  1993-08       Impact factor: 2.031

7.  Combination therapies in ophthalmology: implications for intravitreal delivery.

Authors:  Gholam A Peyman; Kamran Hosseini
Journal:  J Ophthalmic Vis Res       Date:  2011-01

8.  Commentary: Is it time to re-evaluate the empiric intravitreal antibiotic therapy in infectious bacterial endophthalmitis?

Authors:  Taraprasad Das
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.